Invasive fungal infection in chronic granulomatous disease: Insights into pathogenesis and management

Current Opinion in Infectious Diseases

Volumn 25, Issue 6, 2012, Pages 658-669

  Falcone, E Liana ^a   Holland, Steven M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

antifungal prophylaxis; Aspergillus spp.; chronic granulomatous disease; hematopoietic stem cell transplantation; invasive fungal infections

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; CLOTRIMAZOLE; FLUCYTOSINE; GALACTOMANNAN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ITRACONAZOLE; KETOCONAZOLE; MICAFUNGIN; MICONAZOLE; POSACONAZOLE; PREDNISONE; RIFAMPICIN; SULFAFURAZOLE; TERBINAFINE; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; CHRONIC GRANULOMATOUS DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG EFFICACY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMAGE ANALYSIS; OSTEOMYELITIS; PATHOGENESIS; REVIEW; SYSTEMIC MYCOSIS; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; ITRACONAZOLE; MYCOSES; SURGICAL PROCEDURES, OPERATIVE; TRIAZOLES;

EID: 84870059230     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e328358b0a4     Document Type: Review

References (94)

1. Winkelstein JA, Marino MC, Johnston RB Jr., et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79:155-169. (Pubitemid 30327530)
2. Segal BH, Leto TL, Gallin JI, et al. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000; 79:170-200. (Pubitemid 30327531)
3. Kuhns DB, Alvord WG, Heller T, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 2010; 363:2600-2610.
4. Matute JD, Arias AA, Wright NA, et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood 2009; 114:3309-3315.
5. Cale CM, Jones AM, Goldblatt D. Follow up of patients with chronic granulomatous disease diagnosed since 1990. Clin Exp Immunol 2000; 120:351-355. (Pubitemid 30304233)
6. Gallin JI, Malech HL, Melnicj DA, for The International Chronic Granulomatous Disease Cooperative Study. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. N Engl J Med 1991; 324:509-516.
7. Seger RA. Modern management of chronic granulomatous disease. Br J Haematol 2008; 140:255-266.
8. Jones LB, McGrogan P, Flood TJ, et al. Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patientbased registry. Clin Exp Immunol 2008; 152:211-218. (Pubitemid 351520920)
9. Martire B, Rondelli R, Soresina A, et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study. Clin Immunol 2008; 126:155-164.
10. Beauté J, Obenga G, Le Mignot L, et al. Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France. Pediatr Infect Dis J 2011; 30:57-62. The French National Center of Primary Immunodeficiencies (CEREDIH) network cordinates a network of 19 regional centers. This multicenter study assesses the incidence, prevalence, and outcome of invasive fungal infections among CGD patients enrolled in the CEREDIH network.
11. Segal BH, DeCarlo ES, Kwon-Chung KJ, et al. Aspergillus nidulans infection in chronic granulomatous disease. Medicine 1998; 77:345-354. (Pubitemid 28449835)
12. Blumental S, Mouy R, Mahlaoui N, et al. Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey. Clin Infect Dis 2011; 53:e159-e169. This study is a retrospective review of proven episodes of invasive fungal infections in patients with CGD enrolled in the CEREDIH network. It evaluates the clinical and microbiological features, laboratory workups, and outcomes of 29 cases over a 25-year period.
13. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42:1417-1427.
14. Verweij PE, Weemaes CM, Curfs JH, et al. Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis. J Clin Microbiol 2000; 38:3900-3901.
15. Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005; 40:1762-1769. (Pubitemid 40799945)
16. Dennis CG, Greco WR, Brun Y, et al. Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/-mouse model of chronic granulomatous disease. Antimicrob Agents Chemother 2006; 50:422-427. (Pubitemid 43190948)
17. Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39:199-205. (Pubitemid 38971490)
18. Karageorgopoulos DE, Qu JM, Korbila IP, et al. Accuracy of beta-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis. Clin Microbiol Infect 2011. [Epub ahead of print]
19. Pazos C, Ponton J, Del Palacio A. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 2005; 43:299-305. (Pubitemid 40096315)
20. Chang HM, Yu HH, Yang YH, et al. Successful treatment of Aspergillus flavus spondylodiscitis with epidural abscess in a patient with chronic granulomatous disease. Pediatr Infect Dis J 2012; 31:100-101.
21. Dotis J, Roilides E. Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus. Int J Infect Dis 2004; 8:103-110. (Pubitemid 38166076)
22. Segal BH, Romani LR. Invasive aspergillosis in chronic granulomatous disease. Med Mycol 2009; 47 (suppl. 1):S282-S290.
23. Bianchi M, Hakkim A, Brinkmann V, et al. Restoration of NET formation by gene therapy in CGD controls aspergillosis. Blood 2009; 114:2619-2622.
24. Romani L, Fallarino F, De Luca A, et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 2008; 451:211-215.
25. De Ravin SS, Zarember KA, Long-Priel D, et al. Tryptophan/kynurenine metabolism in human leukocytes is independent of superoxide and is fully maintained in chronic granulomatous disease. Blood 2010; 116:1755-1760.
26. Smeekens SP, Henriet SS, Gresnigt MS, et al. Low interleukin-17A production in response to fungal pathogens in patients with chronic granulomatous disease. J Interferon Cytokine Res 2012; 32:159-168. This study examines tryptophan metabolism and interleukin-17A production in patients with CGD. The findings provide some insight into the increased predisposition to fungal infections in CG.D.
27. Puel A, Cypowyj S, Bustamante J, et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 2011; 332: 65-68.
28. Vinh DC, Shea YR, Jones PA, et al. Chronic invasive aspergillosis caused by Aspergillus viridinutans. Emerg Infect Dis 2009; 15:1292-1294.
29. Vinh DC, Shea YR, Sugui JA, et al. Invasive aspergillosis due to Neosartorya udagawae. Clin Infect Dis 2009; 49:102-111.
30. Sugui JA, Peterson SW, Clark LP, et al. Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy. J Clin Microbiol 2012. [Epub ahead of print]
31. Conrad DJ, Warnock M, Blanc P, et al. Microgranulomatous aspergillosis after shoveling wood chips: report of a fatal outcome in a patient with chronic granulomatous disease. Am J Ind Med 1992; 22:411-418.
32. De Sevaux RG, Kullberg BJ, Verweij PE, et al. Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole. Clin Infect Dis 1998; 26:996-997. (Pubitemid 28180347)
33. Ameratunga R, Woon ST, Vyas J, Roberts S. Fulminant mulch pneumonitis in undiagnosed chronic granulomatous disease: a medical emergency. Clin Pediatr 2010; 49:1143-1146.
34. Siddiqui S, Anderson VL, Hilligoss DM, et al. Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease. Clin Infect Dis 2007; 45:673-681. (Pubitemid 47378879)
35. Kwon-Chung KJ, Sugui JA. What do we know about the role of gliotoxin in the pathobiology of Aspergillus fumigatus? Med Mycol 2009; 47 (SUPPL. 1): S97-S103.
36. Waring P, Eichner RD, Mullbacher A, Sjaarda A. Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties. J Biol Chem 1988; 263:18493-18499. (Pubitemid 19005126)
37. Tsunawaki S, Yoshida LS, Nishida S, et al. Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase. Infect Immun 2004; 72:3373-3382. (Pubitemid 38697762)
38. Chai LY, Netea MG, Sugui J, et al. Aspergillus fumigatus conidial melanin modulates host cytokine response. Immunobiology 2010; 215:915-920.
39. Boltansky H, Kwon-Chung KJ, Macher AM, Gallin JI. Acremonium strictumrelated pulmonary infection in a patient with chronic granulomatous disease. J Infect Dis 1984; 149:653. (Pubitemid 14139060)
40. De Ravin SS, Challipalli M, Anderson V, et al. Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease. Clin Infect Dis 2011; 52:e136-e143.
41. Machouart M, Garcia-Hermoso D, Rivier A, et al. Emergence of disseminated infections due to Geosmithia argillacea in patients with chronic granulomatous disease receiving long-term azole antifungal prophylaxis. J Clin Microbiol 2011; 49:1681-1683.
42. Jabado N, Casanova JL, Haddad E, et al. Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease. Clin Infect Dis 1998; 27:1437-1441. (Pubitemid 29242418)
43. Kenney RT, Kwon-Chung KJ, Witebsky FG, et al. Invasive infection with Sarcinosporon inkin in a patient with chronic granulomatous disease. Am J Clin Pathol 1990; 94:344-350. (Pubitemid 20275354)
44. Piwoz JA, Stadtmauer GJ, Bottone EJ, et al. Trichosporon inkin lung abscesses presenting as a penetrating chest wall mass. Pediatr Infect Dis J 2000; 19:1025-1027.
45. Wynne SM, Kwon-Chung KJ, Shea YR, et al. Invasive infection with Trichosporon inkin in 2 siblings with chronic granulomatous disease. J Allergy Clin Immunol 2004; 114:1418-1424. (Pubitemid 39575900)
46. Pastorino AC,Menezes UP, Marques HH, et al. Acremonium kiliense infection in a child with chronic granulomatous disease. Braz J Infect Dis 2005; 9:529-534. (Pubitemid 43130800)
47. Sillevis Smitt JH, Leusen JH, Stas HG, et al. Chronic bullous disease of childhood and a paecilomyces lung infection in chronic granulomatous disease. Arch Dis Child 1997; 77:150-152. (Pubitemid 27398220)
48. Meriden Z, Marr KA, Lederman HM, et al. Ochroconis gallopava infection in a patient with chronic granulomatous disease: case report and review of the literature. Med Mycol 2012; 2:2.
49. Sponseller PD, Malech HL, McCarthy EF Jr., et al. Skeletal involvement in children who have chronic granulomatous disease. J Bone Joint Surg 1991; 73:37-51.
50. Dotis J, Panagopoulou P, Filioti J, et al. Femoral osteomyelitis due to Aspergillus nidulans in a patient with chronic granulomatous disease. Infection 2003; 31:121-124. (Pubitemid 36437729)
51. Dotis J, Roilides E. Osteomyelitis due to Aspergillus species in chronic granulomatous disease: an update of the literature. Mycoses 2011; 54:e686-e696.
52. Shigemura T, Agematsu K, Yamazaki T, et al. Femoral osteomyelitis due to Cladophialophora arxii in a patient with chronic granulomatous disease. Infection 2009; 37:469-473.
53. Davis CM, Noroski LM, Dishop MK, et al. Basidiomycetous fungal Inonotus tropicalis sacral osteomyelitis in X-linked chronic granulomatous disease. Pediatr Infect Dis J 2007; 26:655-656. (Pubitemid 47014174)
54. Santos PE, Piontelli E, Shea YR, et al. Penicillium piceum infection: diagnosis and successful treatment in chronic granulomatous disease. Med Mycol 2006; 44:749-753. (Pubitemid 44824453)
55. Gompels MM, Bethune CA, Jackson G, Spickett GP. Scedosporium apiospermum in chronic granulomatous disease treated with an HLA matched bone marrow transplant. J Clin Pathol 2002; 55:784-786. (Pubitemid 35231915)
56. Cohen-Abbo A, Edwards KM. Multifocal osteomyelitis caused by Paecilomyces variotii in a patient with chronic granulomatous disease. Infection 1995; 23:55-57.
57. Williamson PR, Kwon-Chung KJ, Gallin JI. Successful treatment of Paecilomyces variotii infection in a patient with chronic granulomatous disease and a review of Paecilomyces species infections. Clin Infect Dis 1992; 14:1023-1026.
58. Sutton DA, Thompson EH, Rinaldi MG, et al. Identification and first report of Inonotus (Phellinus) tropicalis as an etiologic agent in a patient with chronic granulomatous disease. J Clin Microbiol 2005; 43:982-987. (Pubitemid 40256078)
59. Alsultan A, Williams MS, Lubner S, Goldman FD. Chronic granulomatous disease presenting with disseminated intracranial aspergillosis. Pediatr Blood Cancer 2006; 47:107-110. (Pubitemid 43787920)
60. Touza Rey F, Martinez Vazquez C, Alonso Alonso J, et al. [The clinical response to interferon-gamma in a patient with chronic granulomatous disease and brain abscesses due to Aspergillus fumigatus]. An Med Interna 2000; 17:86-87. (Pubitemid 30313064)
61. Saulsbury FT. Successful treatment of Aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease. Clin Infect Dis 2001; 32:E137-E139.
62. Patiroglu T, Unal E, Yikilmaz A, et al. Atypical presentation of chronic granulomatous disease in an adolescent boy with frontal lobe located Aspergillus abscess mimicking intracranial tumor. Childs Nerv Syst 2010; 26:149-154.
63. Pollack IF, Pang D, Schuit KE. Chronic granulomatous disease with cranial fungal osteomyelitis and epidural abscess. Case report. J Neurosurg 1987; 67:132-136. (Pubitemid 17085028)
64. Bukhari E, Alrabiaah A. First case of extensive spinal cord infection with Aspergillus nidulans in a child with chronic granulomatous disease. J Infect Dev Ctries 2009; 3:321-323.
65. Dean AF, Janota I, Thrasher A, et al. Cerebral aspergilloma in a child with autosomal recessive chronic granulomatous disease. Arch Dis Child 1993; 68:412-414. (Pubitemid 23084599)
66. Kenney RT, Kwon-Chung KJ, Waytes AT, et al. Successful treatment of systemic Exophiala dermatitidis infection in a patient with chronic granulomatous disease. Clin Infect Dis 1992; 14:235-242.
67. Bhat SV, Paterson DL, Rinaldi MG, Veldkamp PJ. Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: successful combination therapy with voriconazole and terbinafine. Scand J Infect Dis 2007; 39:87-90. (Pubitemid 46277156)
68. Hipolito E, Faria E, Alves AF, et al. Alternaria infectoria brain abscess in a child with chronic granulomatous disease. Eur J Clin Microbiol Infect Dis 2009; 28:377-380.
69. McNeil CJ, Luo RF, Vogel H, et al. Brain abscess caused by Phaeoacremonium parasiticum in an immunocompromised patient. J Clin Microbiol 2011; 49:1171-1174.
70. Mortensen KL, Knudsen JB, Jensen-Fangel S, et al. Successful management of invasive aspergillosis presenting as pericarditis in an adult patient with chronic granulomatous disease. Mycoses 2011; 54:e233-e236.
71. Mansoory D, Roozbahany NA, Mazinany H, Samimagam A. Chronic Fusarium infection in an adult patient with undiagnosed chronic granulomatous disease. Clin Infect Dis 2003; 37:e107-e108.
72. Marques AR, Kwon-Chung KJ, Holland SM, et al. Suppurative cutaneous granulomata caused by Microascus cinereus in a patient with chronic granulomatous disease. Clin Infect Dis 1995; 20:110-114.
73. Phillips P, Forbes JC, Speert DP. Disseminated infection with Pseudallescheria boydii in a patient with chronic granulomatous disease: response to gamma-interferon plus antifungal chemotherapy. Pediatr Infect Dis J 1991; 10:536-539.
74. Roilides E, Sigler L, Bibashi E, et al. Disseminated infection due to Chrysosporium zonatum in a patient with chronic granulomatous disease and review of non-Aspergillus fungal infections in patients with this disease. J Clin Microbiol 1999; 37:18-25. (Pubitemid 29004173)
75. Silliman CC, Lawellin DW, Lohr JA, et al. Paecilomyces lilacinus infection in a child with chronic granulomatous disease. J Infect 1992; 24:191-195.
76. Uenotsuchi T, Moroi Y, Urabe K, et al. Cutaneous alternariosis with chronic granulomatous disease. Eur J Dermatol 2005; 15:406-408. (Pubitemid 41337423)
77. Wang SM, Shieh CC, Liu CC. Successful treatment of Paecilomyces variotii splenic abscesses: a rare complication in a previously unrecognized chronic granulomatous disease child. Diagn Microbiol Infect Dis 2005; 53:149-152.
78. Wildenbeest JG, Oomen MW, Bruggemann RJ, et al. Rhizopus oryzae skin infection treated with posaconazole in a boy with chronic granulomatous disease. Pediatr Infect Dis J 2010; 29:578.
79. Gallin JI, Alling DW, Malech HL, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 2003; 348:2416-2422. (Pubitemid 36682820)
80. Mouy R, Veber F, Blanche S, et al. Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease. J Pediatr 1994; 125:998-1003. (Pubitemid 24379140)
81. Welzen ME, Bruggemann RJ, Van Den Berg JM, et al. A twice daily posaconazole dosing algorithm for children with chronic granulomatous disease. Pediatr Infect Dis J 2011; 30:794-797. This study proposes posaconazole as an alternative to itraconazole for antifungal prophylaxis. The results and safety profile in the pediatric population show promising results.
82. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347:408-415. (Pubitemid 34851833)
83. Walsh TJ, Lutsar I, Driscoll T, et al. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 2002; 21:240-248. (Pubitemid 34214142)
84. Segal BH, Barnhart LA, Anderson VL, et al. Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection. Clin Infect Dis 2005; 40:1684-1688. (Pubitemid 40720823)
85. Ezekowitz RA, Dinauer MC, Jaffe HS, et al. Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. N Engl J Med 1988; 319:146-151.
86. Rex JH, Bennett JE, Gallin JI, et al. In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. J Infect Dis 1991; 163:849-852.
87. Marciano BE, Wesley R, De Carlo ES, et al. Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 2004; 39:692-699. (Pubitemid 39180442)
88. Rex JH, Bennett JE, Gallin JI, et al. Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. J Infect Dis 1990; 162:523-528. (Pubitemid 20239974)
89. Kang EM, Marciano BE, DeRavin S, et al. Chronic granulomatous disease: overview and hematopoietic stem cell transplantation. J Allergy Clin Immunol 2011; 127:1319-1326; quiz 1327-1318. This review focuses on the salient studies examining hematopoietic stem cell transplantation in CGD, while also providing some preliminary data on the NIH transplant experience.
90. Seger RA, Gungor T, Belohradsky BH, et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood 2002; 100:4344-4350. (Pubitemid 35429672)
91. Soncini E, Slatter MA, Jones LB, et al. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth. Br J Haematol 2009; 145:73-83.
92. Schuetz C, Hoenig M, Gatz S, et al. Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease. Immunol Res 2009; 44:35-41.
93. Kang EM, Choi U, Theobald N, et al. Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils. Blood 2010; 115:783-791.
94. Kang HJ, Bartholomae CC, Paruzynski A, et al. Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trial. Mol Ther 2011; 19:2092-2101.